Difference between revisions of "Periampullary adenocarcinoma"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "http://www.esmo.org/" to "https://www.esmo.org/") |
Warner-admin (talk | contribs) m (Text replacement - "</big>" to "") |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 10: | Line 10: | ||
|} | |} | ||
''Are you looking for a regimen, but can't find it here? For placebo or observational studies in this condition, please visit [[Periampullary adenocarcinoma - null regimens|this page]]. If you still can't find it, please let us know so we can add it!'' <br> | ''Are you looking for a regimen, but can't find it here? For placebo or observational studies in this condition, please visit [[Periampullary adenocarcinoma - null regimens|this page]]. If you still can't find it, please let us know so we can add it!'' <br> | ||
| − | + | Note: there is some overlap, especially in the earlier literature, between treatment regimens for periampullary adenocarcinoma and those for '''[[pancreatic cancer|pancreatic adenocarcinoma]]''', '''[[cholangiocarcinoma]]''', and '''[[gallbladder cancer]]'''; please see those pages for additional regimens. | |
{{TOC limit|limit=3}} | {{TOC limit|limit=3}} | ||
=Guidelines= | =Guidelines= | ||
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.''' | '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.''' | ||
==[https://www.esmo.org/ ESMO]== | ==[https://www.esmo.org/ ESMO]== | ||
| − | *'''2016:''' [ | + | *'''2016:''' [https://doi.org/10.1093/annonc/mdw324 Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.] [https://pubmed.ncbi.nlm.nih.gov/27664259/ PubMed] |
==NCCN== | ==NCCN== | ||
Latest revision as of 00:28, 4 July 2024
| Section editor | |
|---|---|
 |
Eric I. Marks, MD Boston University Boston, MA, USA |
0 regimens on this page
0 variants on this page
|
Are you looking for a regimen, but can't find it here? For placebo or observational studies in this condition, please visit this page. If you still can't find it, please let us know so we can add it!
Note: there is some overlap, especially in the earlier literature, between treatment regimens for periampullary adenocarcinoma and those for pancreatic adenocarcinoma, cholangiocarcinoma, and gallbladder cancer; please see those pages for additional regimens.
Guidelines
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
ESMO
- 2016: Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. PubMed